Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercanto HoldingsTGSHF 33 Receivables Turnover is 3.04 as of Apr. 2026. GuruFocus rates TGSHF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 950 Drug Manufacturers companies, Mercanto Holdings ranks better than 91.37% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Mercanto Holdings's Revenue for the
three
months ended in Apr. 2026 was $0.79 Mil. Mercanto Holdings's average Accounts Receivable for the
three
months ended in Apr. 2026 was $0.26 Mil.
Hence, Mercanto Holdings's Receivables Turnover for the
three
months ended in Apr. 2026 was 3.04.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Mercanto Holdings Receivables Turnover Related Terms
Mercanto Holdings Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Mercanto Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TGSHF vs ZTS, UTHR: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Mercanto Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercanto Holdings Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mercanto Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Mercanto Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercanto Holdings (TGSHF) has a Receivables Turnover of 3.04 as of Apr. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Mercanto Holdings and its competitors. According to the industry distribution chart, Mercanto Holdings ranks #82 out of 950 companies in the Drug Manufacturers industry, placing it in the top 8.6%.
Is Mercanto Holdings' Receivables Turnover too high?
Mercanto Holdings' current Receivables Turnover is 3.04. The Drug Manufacturers industry median Receivables Turnover is 5.07. Mercanto Holdings' value of 3.04 is 40% below this industry median. Based on the distribution chart, Mercanto Holdings ranks #82 out of 950 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Mercanto Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Mercanto Holdings' Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mercanto Holdings ranks #82 out of 950 companies for Receivables Turnover. This places Mercanto Holdings in the top 9% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Mercanto Holdings' value of 3.04 is 40% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercanto Holdings's current Receivables Turnover of 3.04 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Mercanto Holdings and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercanto Holdings's current Receivables Turnover is 3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercanto Holdings stock overvalued right now?
Mercanto Holdings (TGSHF) has a current Receivables Turnover of 3.04. The current Receivables Turnover is 3.04 and 40% below the Drug Manufacturers industry median of 5.07. Mercanto Holdings' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Mercanto Holdings (TGSHF), the current Receivables Turnover is 3.04 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.
33GF Score
Get the complete analysis for TGSHF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGSHF has been successfully added to your 
